Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.9K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

5.5K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.5K
Dementia01:30

Dementia

672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
672
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

1.0K
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CIT tumor lines: A series of immunogenic murine cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis.

JID innovations : skin science from molecules to population health·2026
Same author

Life-course trajectories and modifiable risk factors for incident walking limitation and mortality in 25 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

The lancet. Healthy longevity·2026
Same author

Calcitonin Receptor is a Novel Biomarker for NF-κB-Mediated Cellular Stress in Triple-Negative Breast Cancer Cells.

Frontiers in bioscience (Landmark edition)·2026
Same author

External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy-associated genetic variants.

Heart rhythm·2026
Same author

Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.

bioRxiv : the preprint server for biology·2026
Same author

RBM20 Truncating Variants and Human Cardiomyopathy.

JAMA cardiology·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.5K

Vascular Cognitive Impairment.

Eric Smith

    Continuum (Minneapolis, Minn.)
    |April 5, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Vascular cognitive impairment is a common cause of cognitive decline. Early diagnosis and management of cerebrovascular disease can slow or halt its progression.

    More Related Videos

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
    05:12

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

    Published on: November 22, 2024

    1.6K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Related Experiment Videos

    Last Updated: Mar 23, 2026

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
    07:30

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

    Published on: April 23, 2021

    3.5K
    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
    05:12

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

    Published on: November 22, 2024

    1.6K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Area of Science:

    • Neurology
    • Geriatrics
    • Neuroscience

    Background:

    • Vascular cognitive impairment (VCI) is a significant cause of cognitive decline.
    • It frequently co-occurs with other neurodegenerative diseases, complicating diagnosis and management.

    Observation:

    • Recent diagnostic criteria emphasize classifying impairment (mild cognitive impairment or dementia) and linking it to cerebrovascular disease.
    • VCI can be subclassified into post-stroke and non-stroke types, with cerebral small vessel disease being a common non-stroke cause often identified via neuroimaging.

    Findings:

    • VCI is the second leading cause of cognitive impairment.
    • New diagnostic criteria provide a clearer framework for identifying and classifying VCI.
    • Cerebral small vessel disease is a key contributor to non-stroke VCI.

    Implications:

    • VCI is a treatable condition.
    • Secondary prevention of vascular disease is crucial for slowing or halting VCI progression.
    • Improved diagnostic frameworks enhance patient management and outcomes.